MilestoneHealthcare & Life Sciences
Innovaccer completes Rs 600 crore ESOP buyback
By Abha Lohia · Editor ·
Innovaccer: revenue, valuation and funding and every story →
Founded 2014
- Innovaccer is a healthcare data and analytics platform for hospitals, health systems, and insurers
- The company completed a Rs 600 crore (~$75 million) ESOP buyback, providing liquidity to current and former employees with vested stock options
- The buyback follows a $275 million Series F round last year and comes amid muted ESOP activity in 2025
What happened
- Innovaccer completed an ESOP buyback (employee stock option plan buyback, where the company repurchases shares from employees' vested stock options) worth Rs 600 crore (~$75 million).
- The buyback provided liquidity to current and former employees with vested stock options.
- CEO Abhinav Shashank said the buyback aimed to convert employee ownership into tangible outcomes.
- The buyback involved repurchasing shares from exercised stock options, with no new shares issued or dilution.
- The buyback follows the company's $275 million Series F round last year.
- Series F participants included B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente, and M12.
- The buyback comes amid muted ESOP activity in 2025, with total ESOP buybacks, payouts, and liquidity at just over $75 million for the year.
Why it matters
- The buyback is part of Innovaccer's strategy to reward employees and convert their ownership into tangible financial outcomes.
- It follows a $275 million Series F round, indicating strong investor confidence and available capital.
- The buyback occurs against a backdrop of declining ESOP liquidity in the Indian startup ecosystem, with 2025 activity at just over $75 million compared to $190 million in 2024.
- The company's strong financial performance, with Rs 387.71 crore operating revenue and Rs 36.1 crore profit in FY ended March 2025, supports such liquidity events.
The business
- Innovaccer is a healthcare data and analytics platform for hospitals, health systems, and insurers.
- Its products include the Healthcare Intelligence Cloud and Data Activation Platform, which unify EHR (electronic health records), claims, and other data.
- Key customers include CommonSpirit Health, Kaiser Permanente, and Banner Health.
- The company has a strong footprint in the US healthcare market, working with provider networks and payers.
- Innovaccer generates revenue by selling its platform to healthcare organizations, with operating revenue of Rs 387.71 crore in FY ended March 2025.
- The company has made several acquisitions, including Cured (patient experience/CRM) and Pharmacy Quality Solutions (pharmacy performance) in 2024.
- In September 2025, it acquired Story Health (AI-enabled specialty care) and Humbi AI (actuarial and contracting copilots).
- New product launches include Innovaccer Gravity (healthcare intelligence platform for AI operationalisation), Flow (AI-driven prior authorisation), and Comet (AI-powered access centre).
The founders
AS
Abhinav Shashank
CEO- Co-founded Innovaccer in 2014.
- As CEO, he leads the company's strategic direction.
- He emphasized the buyback's goal of converting employee ownership into tangible outcomes.
KH
Kanav Hasija
Co-founder- Co-founded Innovaccer in 2014.
SG
Sandeep Gupta
Co-founder- Co-founded Innovaccer in 2014.
In numbers
Rs 600 croreESOP buyback amount · 2026
$75 millionESOP buyback amount (USD) · 2026
$275 millionSeries F round · 2025
Rs 387.71 croreOperating revenue · FY ended March 2025
Rs 36.1 croreProfit · FY ended March 2025
$75 millionTotal ESOP liquidity 2025
$190 millionTotal ESOP liquidity 2024
$802 millionTotal ESOP liquidity 2023
$440 millionTotal ESOP liquidity 2022
$200 millionTotal ESOP liquidity 2021
Earlier rounds
- 2025 · Series F · $275 million
Words to know
- ESOP
- Employee Stock Option Plan, a benefit that gives employees the right to buy company shares at a set price.
- Buyback
- When a company repurchases its own shares from shareholders, often to provide liquidity.
- Vested stock options
- Options that have matured and can be exercised, giving the holder the right to buy shares.
- Dilution
- Reduction in existing shareholders' ownership percentage due to issuing new shares.
The numbers around it
Innovaccer has 3 funding rounds in StopDown's archive, $675 million raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 9 January 2025 | Series F | $275M | Kaiser Permanente |
| 15 December 2021 | Series E | $150M | Mubadala Capital |
| 15 February 2021 | Series D | $105M | Tiger Global Management |
Healthcare & Life Sciences in January 2026: 12 rounds with a disclosed amount, $99.0 million in all; the biggest was Sukino ($31M). Every sector this year →
Other articles talking about it
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
- ESOP buyback: An ESOP buyback is when a company uses its own cash to buy back shares that employees have earned through stock options. Under the Companies Act a buyback is generally capped at 25% of paid-up capital and free reserves a year, and no outside investor is involved.
- ESOP: An ESOP (employee stock option plan) is a company's promise that an employee may buy a set number of shares later at a price fixed today. In India a private company needs a special resolution to run one, and one year must pass between grant and first vesting. Options pay off only at a sale, listing or buyback.
Read next
FundingInnovaccer raises $275M in Series F roundInnovaccer builds a healthcare AI platform that unifies patient data across electronic health records, insurers, and labsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Innovaccer → · All startup news on 13 January 2026 →
Is this Innovaccer? Get your “Featured on StopDown” badge →